Sodium nitroprusside: a review of its clinical effectiveness as a hypotensive agent.
D000284:Administration, Oral; D000328:Adult; D000375:Aging; D000758:Anesthesia; D000792:Angiography; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D005292:Ferricyanides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000175:diagnosis; D009203:Myocardial Infarction / Q000188:drug therapy; D009569:Nitric Oxide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D012083:Renin / Q000378:metabolism; D013618:Tachyphylaxis / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D000959:Antihypertensive Agents; D005292:Ferricyanides; D014665:Vasodilator Agents; D009569:Nitric Oxide; D012083:Renin